BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 15600238)

  • 1. Metallo-beta-lactamase inhibitors: promise for the future?
    Toney JH; Moloughney JG
    Curr Opin Investig Drugs; 2004 Aug; 5(8):823-6. PubMed ID: 15600238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the longevity of the beta-lactam antibiotics and of antibiotic/beta-lactamase inhibitor combinations.
    Buynak JD
    Biochem Pharmacol; 2006 Mar; 71(7):930-40. PubMed ID: 16359643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel IMP-1 metallo-beta-lactamase inhibitors can reverse meropenem resistance in Escherichia coli expressing IMP-1.
    Moloughney JG; D Thomas J; Toney JH
    FEMS Microbiol Lett; 2005 Feb; 243(1):65-71. PubMed ID: 15668002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclobutanone analogues of beta-lactams revisited: insights into conformational requirements for inhibition of serine- and metallo-beta-lactamases.
    Johnson JW; Gretes M; Goodfellow VJ; Marrone L; Heynen ML; Strynadka NC; Dmitrienko GI
    J Am Chem Soc; 2010 Mar; 132(8):2558-60. PubMed ID: 20141132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward better antibiotics: crystallographic studies of a novel class of DD-peptidase/beta-lactamase inhibitors.
    Silvaggi NR; Kaur K; Adediran SA; Pratt RF; Kelly JA
    Biochemistry; 2004 Jun; 43(22):7046-53. PubMed ID: 15170342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-lactams and beta-lactamase-inhibitors in current- or potential-clinical practice: a comprehensive update.
    Shahid M; Sobia F; Singh A; Malik A; Khan HM; Jonas D; Hawkey PM
    Crit Rev Microbiol; 2009; 35(2):81-108. PubMed ID: 19514910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescein-labeled beta-lactamase mutant for high-throughput screening of bacterial beta-lactamases against beta-lactam antibiotics.
    Chan PH; Chan KC; Liu HB; Chung WH; Leung YC; Wong KY
    Anal Chem; 2005 Aug; 77(16):5268-76. PubMed ID: 16097768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Beta-lactamases and their role in resistance. PART 2: beta-lactamases in 21st century].
    Bedenić B
    Lijec Vjesn; 2005; 127(1-2):12-21. PubMed ID: 16145868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanistic and clinical aspects of beta-lactam antibiotics and beta-lactamases.
    Kotra LP; Mobashery S
    Arch Immunol Ther Exp (Warsz); 1999; 47(4):211-6. PubMed ID: 10483868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of peroxidase-catalyzed iodination by cephalosporins: Metallo-beta-lactamase-induced antithyroid activity of antibiotics.
    Tamilselvi A; Mugesh G
    ChemMedChem; 2009 Apr; 4(4):512-6. PubMed ID: 19107757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Side chain SAR of bicyclic β-lactamase inhibitors (BLIs). 2. N-Alkylated and open chain analogs of MK-8712.
    Chen H; Blizzard TA; Kim S; Wu J; Young K; Park YW; Ogawa AM; Raghoobar S; Painter RE; Wisniewski D; Hairston N; Fitzgerald P; Sharma N; Scapin G; Lu J; Hermes J; Hammond ML
    Bioorg Med Chem Lett; 2011 Jul; 21(14):4267-70. PubMed ID: 21676616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology.
    Poirel L; Nordmann P
    Clin Microbiol Infect; 2006 Sep; 12(9):826-36. PubMed ID: 16882287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metallo-beta-lactamase inhibitors: could they give old antibacterials new life?
    Toney JH
    Curr Opin Investig Drugs; 2003 Feb; 4(2):115-6. PubMed ID: 12669370
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative activity of beta-lactamase inhibitors combined with beta-lactams against antibiotic-resistant enterobacter.
    Tejedor-Junco MT; Gonzalez-Martin M; Lupiola PA; Santana OE; Lopez-Orge RH; Gonzalez-Lama Z
    J Chemother; 1989 Jul; 1(4 Suppl):346-8. PubMed ID: 16312432
    [No Abstract]   [Full Text] [Related]  

  • 15. 4,7-Dichloro benzothien-2-yl sulfonylaminomethyl boronic acid: first boronic acid-derived beta-lactamase inhibitor with class A, C, and D activity.
    Tan Q; Ogawa AM; Painter RE; Park YW; Young K; DiNinno FP
    Bioorg Med Chem Lett; 2010 Apr; 20(8):2622-4. PubMed ID: 20299220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mechanisms of resistance to beta-lactam inhibitors of beta-lactamases].
    Blázquez J
    Rev Esp Quimioter; 1998 Dec; 11(4):368-9. PubMed ID: 10336318
    [No Abstract]   [Full Text] [Related]  

  • 17. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
    Susić E
    Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A specific peptide inhibitor of the class B metallo-beta-lactamase L-1 from Stenotrophomonas maltophilia identified using phage display.
    Sanschagrin F; Levesque RC
    J Antimicrob Chemother; 2005 Feb; 55(2):252-5. PubMed ID: 15659541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evolution of resistance to beta-lactam inhibitors of beta-lactamases].
    Alóz JI
    Rev Esp Quimioter; 1998 Dec; 11(4):375-6. PubMed ID: 10336321
    [No Abstract]   [Full Text] [Related]  

  • 20. [Problems in the detection of resistance to beta-lactam inhibitors of beta-lactamases in the laboratory].
    Castillo García FJ
    Rev Esp Quimioter; 1998 Dec; 11(4):372-4. PubMed ID: 10336320
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.